KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc., a specialist GPCR drug discovery company, today announced that John LaMattina and Robert Ruffolo will join scientific founders Howard Rockman and Robert Lefkowitz on its Scientific Advisory Board.